Dems May Scale Back Medicare, Drug Pricing Asks In Infrastructure Bill
The “social infrastructure” items in the $2 trillion-plus bill may need to be narrowed, Politico reports. Meanwhile, it was a busy day of health care hearings on Capitol Hill.
The independent source for health policy research, polling, and news.
15,581 - 15,600 of 112,572 Results
The “social infrastructure” items in the $2 trillion-plus bill may need to be narrowed, Politico reports. Meanwhile, it was a busy day of health care hearings on Capitol Hill.
Most recently, the Biden administration has moved against an exemption of a wide swath of medical devices and artificial intelligence tools from regulatory review and federal research that uses fetal tissue.
Dr. Anthony Fauci thinks the Johnson & Johnson vaccine will get back on track. He sparred with Ohio Republican Rep. Jim Jordan during a congressional hearing.
At least 21 states have recorded at least a 10% rise in daily average positive covid cases. Overall, the U.S. has over 70,000 new covid cases a day. Hospitals are again getting stressed. (And two tigers in captivity in Virginia have tested positive.)
As Merck reports results for its anti-covid pill that are promising, if only in the early stages of infection, other researchers say the P1 variant from Brazil is more transmissible than others. Worries emerge about next-gen covid vaccines. And one study shows dogs can sniff out covid-positive urine.
About 30% of American adults have been fully vaccinated, according to the CDC. Meanwhile, the list of colleges that require covid vaccination is growing.
Pfizer's CEO says that people who received his company's covid vaccine will probably need a third shot within 12 months of the original two-dose regimen. And Moderna targets the fall to have its expected booster shot available.
Despite a study out of Oxford University showing the risk of blood clots is much higher with covid than with a vaccine against covid, the Johnson & Johnson vaccine continues to generate suspicion.
Today's early morning highlights from the major news organizations.
Opinion writers weigh in on Covid and vaccine news.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
Editorial pages take on these public health issues.
As the NCAA rattles its saber in warning about anti-trans discrimination, Texas, Florida and West Virginia made legal moves to limit the rights of trans children to play sports. Arizona, meanwhile, plans laws to further restrict what can be taught in sex ed.
More than a dozen hotels and wedding banquet halls were ordered to be converted into covid-19 centers attached to hospitals as India goes past 14 million covid cases. In other global news, Germany will prosecute vaccine line-jumpers, and the E.U. shifts its efforts to the Pfizer vaccine.
Officials in Nevada want Las Vegas back to normal by June 1, and California's governor urges all school systems to open schools again. Meanwhile, a Florida county wants to do away with the requirement that masks be worn inside public places.
A study in London compared psilocybin and escitalopram (Lexapro) and found them equivalent for treating depression. In other research news, snoring is linked to learning difficulties for kids, and DDT is found to impact another generation's health.
Michigan and Oregon hospitals are hit hard. In other health care industry news, Cleveland's University Hospitals made as much money last year as the year before, Massachusetts to "crack down" on high-cost hospitals and a VA hospital wastes $172,000 in stents.
The Biden administration proposed the repeal of Trump-era regulations barring abortion referrals and making other changes intended to evict Planned Parenthood and other abortion providers from the federal family planning program, Title X.
Under sequestration, the recent stimulus bill would have triggered budget reductions to Medicare as well as other social safety net programs. This bill pushes such cuts off until at least the end of the year. The Centers for Medicare & Medicaid Services also announces hospital pricing transparency policies.
The Food and Drug Administration is urged to work up policies for drugs withdrawn after being deemed unsafe or ineffective. It also is working on new rules for approving old drugs in order to replace the unsuccessful Unapproved Drug Initiative.
© 2026 KFF